Get our introductory offer at only
*$0.99/month for first 3 months
$29.90/month for the next 9 months
US drugmakers got a strong start to the year with help from the newest cancer medications, which take advantage of cutting-edge research and have the price tags to prove it.
Pfizer Inc, Merck & Co and Bristol-Myers Squibb Co all beat Wall Street's earnings projections